Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Fortress Biotech (FBIO) Return on Equity (2016 - 2025)

Historic Return on Equity for Fortress Biotech (FBIO) over the last 13 years, with Q3 2025 value amounting to 1.38%.

  • Fortress Biotech's Return on Equity fell 100600.0% to 1.38% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.38%, marking a year-over-year decrease of 100600.0%. This contributed to the annual value of 5.34% for FY2024, which is 10900.0% down from last year.
  • Fortress Biotech's Return on Equity amounted to 1.38% in Q3 2025, which was down 100600.0% from 2.9% recorded in Q2 2025.
  • Fortress Biotech's 5-year Return on Equity high stood at 12.03% for Q3 2023, and its period low was 112.78% during Q2 2023.
  • Over the past 5 years, Fortress Biotech's median Return on Equity value was 1.38% (recorded in 2025), while the average stood at 9.08%.
  • Its Return on Equity has fluctuated over the past 5 years, first crashed by -1115400bps in 2023, then soared by 1238600bps in 2024.
  • Fortress Biotech's Return on Equity (Quarter) stood at 0.84% in 2021, then tumbled by -226bps to 2.75% in 2022, then tumbled by -1048bps to 31.62% in 2023, then grew by 27bps to 23.21% in 2024, then surged by 94bps to 1.38% in 2025.
  • Its Return on Equity was 1.38% in Q3 2025, compared to 2.9% in Q2 2025 and 3.69% in Q1 2025.